Living donor liver transplantation (LDLT) is safe and effective for hepatitis C recipients.

被引：0
|
作者：
Fahmy, A [1 ]
O'Mahony, CA [1 ]
Kaul, H [1 ]
Morgan, GR [1 ]
John, D [1 ]
Diflo, T [1 ]
Teperman, L [1 ]
机构：
[1] NYU Med Ctr, New York, NY 10016 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2004年 / 4卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
724
引用
收藏
页码：355 / 355
页数：1
相关论文
共 50 条
  • [21] Sofosbuvir and daclatasvir are safe and effective in treatment of recurrent hepatitis C virus in Egyptian patients underwent living donor liver transplantation
    Osama Aboelfotoh Aly
    Wael Ahmed Yousry
    Nahla Mohamed Teama
    Eman Mohammed Shona
    Ahmed Mohamed ElGhandour
    Egyptian Liver Journal, 10 (1)
  • [22] Weaning of Immunosuppression in Living Donor Liver Transplant Recipients.
    Takatsuki, Mitsuhisa
    Soyama, Akihiko
    Torashima, Yasuhiro
    Ohno, Shinichiro
    Kinoshita, Ayaka
    Natsuda, Koji
    Fujii, Mio
    Adachi, Tomohiko
    Kitasato, Amane
    Kuroki, Tamotsu
    Eguchi, Susumu
    LIVER TRANSPLANTATION, 2013, 19 : S90 - S90
  • [23] THE IMPACT OF DONOR AND RECIPIENTS SINGLE NUCLEOTIDE POLYMORPHISMS OF LIVING FIBROSIS PROGRESSION IN LIVING LIVER TRANSPLANTATION FOR HEPATITIS C
    Miyaaki, H.
    Ichikawa, T.
    Taura, N.
    Miuma, S.
    Shibata, H.
    Honda, T.
    Nakaoa, K.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S307 - S307
  • [24] Thymoglobulin significantly reduces the risk of acute rejection in right lobe living-donor liver transplant (LDLT) recipients.
    Cattral, MS
    McGilvray, I
    Adcock, L
    Lilly, L
    Girgrah, N
    Levy, GA
    Greig, PD
    Grant, DR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 528 - 528
  • [25] Hepatitis C-positive donor liver transplantation for hepatitis C seronegative recipients
    Ting, Peng-sheng
    Hamilton, James Peter
    Gurakar, Ahmet
    Urrunaga, Nathalie H.
    Ma, Michelle
    Glorioso, Jaime
    King, Elizabeth
    Toman, Lindsey P.
    Wesson, Russell
    Garonzik-Wang, Jacqueline
    Ottmann, Shane
    Philosophe, Benjamin
    Sulkowski, Mark
    Cameron, Andrew M.
    Durand, Christine M.
    Chen, Po-Hung
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (06)
  • [26] Comparison of histological progression of recurrent HCV infection in live donor (LDLT) versus cadaveric liver transplantation (CLT) recipients.
    Zaghla, H
    Kanel, GC
    Donovan, JA
    Kahn, JA
    Genyk, Y
    Ramicone, E
    Selby, RR
    Fong, TL
    HEPATOLOGY, 2003, 38 (04) : 652A - 652A
  • [27] Living donor liver transplantation for hepatitis B and C cirrhosis
    Sugawara, Y
    Makuuchi, M
    THERAPY FOR VIRAL HEPATITIS AND PREVENTION OF HEPATOCELLULAR CARCINOMA, 2004, : 283 - 292
  • [28] HEPATITIS C RECURRENCE FOLLOWING DECEASED DONOR LIVER LIVER TRANSPLANTATION VERSUS LIVING DONOR LIVER TRANSPLANTATION
    Kashkoush, Samy M.
    Abdullah, Khalid O.
    Shaheen, Mohammed F.
    Aijumah, Abdulrahman
    Altraif, Ibrahim H.
    Alalwan, Abduljaleel
    Elhanafi, Sherif
    O'Hali, Wael A.
    LIVER TRANSPLANTATION, 2009, 15 (07) : S184 - S185
  • [29] Hepatitis C Virus Recurrence in Living Donor Liver Transplant Recipients
    Hector Rodriguez-Luna
    Hugo E. Vargas
    Pratima Sharma
    Jose Ortiz
    Giovanni De Petris
    Vijayan Balan
    Thomas Byrne
    Adyr Moss
    David Mulligan
    Jorge Rakela
    David D. Douglas
    Digestive Diseases and Sciences, 2004, 49 : 38 - 41
  • [30] Hepatitis C virus recurrence in living donor liver transplant recipients
    Rodriguez-Luna, H
    Vargas, HE
    Sharma, P
    Ortiz, J
    De Petris, G
    Balan, V
    Byrne, T
    Moss, A
    Mulligan, D
    Rakela, J
    Douglas, DD
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (01) : 38 - 41
12345